Document
type: Class

Anualidad
type: Class

Information Content Entity
type: Class

Continuant
type: Class

Conference Poster
type: Class

Entity
type: Class

Congress communication
type: Class

Generically Dependent Continuant
type: Class

2015
type: Class

individual
type: Document
rights: termsOfUse
date: 2026-08-03T05:21:45
publisher: PTK6 inhibition potentiates the effects of the EGFR antibody cetuximab and the small tyrosine kinase inhibitors on pancreatic carcinoma cell lines proliferation
label: RDF description of PTK6 inhibition potentiates the effects of the EGFR antibody cetuximab and the small tyrosine kinase inhibitors on pancreatic carcinoma cell lines proliferation - http://research.umh.es/vivo/pub/comunicacion/162057

PTK6 inhibition potentiates the effects of the EGFR antibody cetuximab and the small tyrosine kinase inhibitors on pancreatic carcinoma cell lines proliferation
type: Entity
most specific type: 2015
type: Information Content Entity
type: Congress communication
related by: Autor:121773-Comunicación:162057
most specific type: Congress communication
type: Thing
type: Document
type: Continuant
type: Anualidad
related by: Autor:28249-Comunicación:162057
related by: Autor:3718-Comunicación:162057
page start: 16
type: Generically Dependent Continuant
type: Conference Poster
type: 2015
page end: 17
date time value: 162057 pubdate
ARG_2000028: 162057 vcard
RO_0002353: 18TH ECCO - 40TH ESMO EUROPEAN CANCER CONGRESS
related by: Autor:4203-Comunicación:162057
most specific type: Conference Poster
related by: Autor:4053-Comunicación:162057

Autor:121773-Comunicación:162057
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: PTK6 inhibition potentiates the effects of the EGFR antibody cetuximab and the small tyrosine kinase inhibitors on pancreatic carcinoma cell lines proliferation

Autor:28249-Comunicación:162057
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: PTK6 inhibition potentiates the effects of the EGFR antibody cetuximab and the small tyrosine kinase inhibitors on pancreatic carcinoma cell lines proliferation

Autor:3718-Comunicación:162057
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: PTK6 inhibition potentiates the effects of the EGFR antibody cetuximab and the small tyrosine kinase inhibitors on pancreatic carcinoma cell lines proliferation

18TH ECCO - 40TH ESMO EUROPEAN CANCER CONGRESS
type: BFO_0000003
type: Anualidad
type: Conference
type: Thing
type: 2015
type: Event
type: Entity
type: BFO_0000015
RO_0002234: PTK6 inhibition potentiates the effects of the EGFR antibody cetuximab and the small tyrosine kinase inhibitors on pancreatic carcinoma cell lines proliferation

Autor:4203-Comunicación:162057
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: PTK6 inhibition potentiates the effects of the EGFR antibody cetuximab and the small tyrosine kinase inhibitors on pancreatic carcinoma cell lines proliferation

Autor:4053-Comunicación:162057
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: PTK6 inhibition potentiates the effects of the EGFR antibody cetuximab and the small tyrosine kinase inhibitors on pancreatic carcinoma cell lines proliferation